L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,200
-6,700 (-9.59%)
Apr 30, 2026, 3:30 PM KST
Market Cap1.57T +246.1%
Revenue (ttm)85.48B +18.7%
Net Income-138.17B
EPS-5,819.37
Shares Out24.85M
PE Ration/a
Forward PEn/a
Dividend50.00 (0.07%)
Ex-Dividend DateDec 29, 2025
Volume546,913
Average Volume217,269
Open69,300
Previous Close69,900
Day's Range62,400 - 69,300
52-Week Range21,400 - 125,000
Beta1.61
RSI37.26
Earnings DateMar 24, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

Financial Statements